title: Evaluation of PCR-based testing for surveillance of KPC-producing carbapenem-resistant members of the Enterobacteriaceae family.
abstract: The spread of carbapenem-resistant members of the Enterobacteriaceae family (CRE) harboring carbapenemases is an emerging public health threat. As KPC-producing Klebsiella species are endemic in our tertiary care hospital, we aimed to evaluate a PCR-based surveillance test for identification of rectal carriage of KPC-producing CRE. We conducted a surveillance study between May and December 2007. Rectal swabs were collected from patients known to harbor CRE and from contacts of newly discovered patients harboring CRE. Specimens were evaluated by culture and by PCR analysis for blaKPC and were defined as positive if CRE was cultured and blaKPC was identified. Discrepant results between the culture and PCR analysis were resolved by subculturing, repeating the PCR, and performing a hydrolysis assay. Positive CRE cultures prior or subsequent to the time of sampling for the study were also taken into consideration. Sensitivity, specificity, and time to result were calculated. A total of 755 swabs were included. Concordant results were documented for 735 specimens; 51 were positive as determined by both PCR and culture. Discrepancies existed for 20 swabs; 9 were blaKPC negative and CRE culture positive, and 11 were blaKPC positive and CRE culture negative. After repeat testing, a total of 64 samples were classified as blaKPC-positive CRE. The sensitivity and specificity of the PCR analysis were 92.2% and 99.6%, respectively, and those of the culture were 87.5% and 99.4%, respectively. Over the last 3 months of the study, the sensitivity of the PCR improved to 96.3%, versus 77.8% for culture. Time to result was 30 h for the PCR and 60 h (negative) and 75 h (positive) for the CRE culture. blaKPC PCR-based testing is a useful method for the surveillance of KPC-producing CRE. Its main advantage over culturing is a shorter time to result, and it may prove to be more sensitive.
authors.affiliation: Division of Epidemiology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
authors.forename: Vered
authors.initials: V
authors.lastname: Schechner
authors.forename: Keren
authors.initials: K
authors.lastname: Straus-Robinson
authors.forename: David
authors.initials: D
authors.lastname: Schwartz
authors.forename: Iris
authors.initials: I
authors.lastname: Pfeffer
authors.forename: Jalal
authors.initials: J
authors.lastname: Tarabeia
authors.forename: Rina
authors.initials: R
authors.lastname: Moskovich
authors.forename: Inna
authors.initials: I
authors.lastname: Chmelnitsky
authors.forename: Mitchell J
authors.initials: MJ
authors.lastname: Schwaber
authors.forename: Yehuda
authors.initials: Y
authors.lastname: Carmeli
authors.forename: Shiri
authors.initials: S
authors.lastname: Navon-Venezia
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D015780:Carbapenems / Q000494:pharmacology*; D004755:Enterobacteriaceae / Q000201:enzymology* / Q000235:genetics; D005243:Feces / Q000382:microbiology; D006801:Humans; D008826:Microbial Sensitivity Tests; D016133:Polymerase Chain Reaction / Q000379:methods*; D012680:Sensitivity and Specificity; D018440:beta-Lactam Resistance; D001618:beta-Lactamases / Q000096:biosynthesis* / Q000235:genetics*
chemical_list: D000900:Anti-Bacterial Agents; D015780:Carbapenems; D001618:beta-Lactamases
references.citation: Antimicrob Agents Chemother. 2006 Oct;50(10):3396-406
references.pmid: 17005822
references.citation: Antimicrob Agents Chemother. 1997 Mar;41(3):563-9
references.pmid: 9055993
references.citation: Clin Infect Dis. 2002 Oct 1;35(7):834-41
references.pmid: 12228820
references.citation: Clin Infect Dis. 2004 Jul 1;39(1):55-60
references.pmid: 15206053
references.citation: Clin Microbiol Rev. 2007 Jul;20(3):440-58, table of contents
references.pmid: 17630334
references.citation: JAMA. 2008 Dec 24;300(24):2911-3
references.pmid: 19109119
references.citation: J Clin Microbiol. 2005 Nov;43(11):5639-41
references.pmid: 16272497
references.citation: Antimicrob Agents Chemother. 2008 Mar;52(3):1028-33
references.pmid: 18086836
references.citation: N Engl J Med. 2001 May 10;344(19):1427-33
references.pmid: 11346807
references.citation: Antimicrob Agents Chemother. 2004 Dec;48(12):4793-9
references.pmid: 15561858
references.citation: Int J Antimicrob Agents. 2007 Dec;30(6):525-9
references.pmid: 17931835
references.citation: Antimicrob Agents Chemother. 2007 Aug;51(8):3026-9
references.pmid: 17562800
references.citation: Emerg Infect Dis. 2006 Aug;12(8):1209-13
references.pmid: 16965699
references.citation: J Clin Microbiol. 2008 Sep;46(9):2879-83
references.pmid: 18614657
references.citation: Antimicrob Agents Chemother. 2009 Feb;53(2):818-20
references.pmid: 19029323
references.citation: Clin Microbiol Infect. 2001 Feb;7(2):88-91
references.pmid: 11298149
references.citation: Antimicrob Agents Chemother. 2008 Apr;52(4):1413-8
references.pmid: 18227191
references.citation: Eur J Clin Microbiol Infect Dis. 2009 Mar;28(3):309-11
references.pmid: 18719955
references.citation: J Clin Microbiol. 2007 Aug;45(8):2723-5
references.pmid: 17581941
references.citation: Clin Infect Dis. 1999 Dec;29(6):1411-8
references.pmid: 10585788
references.citation: Crit Care. 2006 Feb;10(1):R25
references.pmid: 16469125
references.citation: Antimicrob Agents Chemother. 2006 Sep;50(9):3098-101
references.pmid: 16940107
references.citation: J Hosp Infect. 2007 Jan;65(1):24-8
references.pmid: 17145100